News & Press: Breaking News

Survey of cellular therapy and regenerative medicine in Europe - Patients Treated in 2016

Tuesday, November 21, 2017  
Share |

Dear colleagues,

We continue to collect data to establish a comprehensive, quantitative map of patients being treated in Europe with cellular and engineered tissue therapies (i.e. any clinical treatment based on living cells excluding DLI, donor lymphocyte infusions, and hematopoietic stem cells for hematological reconstitution). The survey is backed by the ISCT and TERMIS-EU and supported by 3 further international organizations as shown above.

If, in 2016, you treated patients with cellular or engineered tissue therapies in Europe or a non-EU EBMT associated country (Algeria, Iran, Israel, Jordan, Lebanon, Nigeria, Saudi Arabia, South Africa or Tunisia) and would like to see your name listed among the 150 or so participating teams, please download and complete the survey form from this page and send it no later than 13th of January 2018 to Max Gay by Email: max.g@usb.ch

Please send us an email if you have practiced such therapies in the past or have them in preparation for the coming years. This way we can also ascertain the variety of teams capable of performing such therapies. You would also be listed in the report.

We strive to make the results available to the scientific community much earlier than in past editions and to achieve this we ask for your response as soon as possible. Please do not forget to identify in the questionnaire to which of the 5 supporting societies, if any, you belong.  As always, if you know of any group that is performing such therapies please forward this message to them and encourage them to participate. This will help us to have a much more effective impact on the scientific, clinical and regulatory aspects of this continually evolving sector of cellular and engineered tissue therapies.

Previous survey reports which include the number of treated patients, without any reference to clinical outcomes, information on specific cell types, processes and delivery modes in use as well as an appendix listing active teams together with the survey form and guidelines can be found on this page.

Thank you and with our best regards.

Prof. Ivan Martin PhD 
Depts. of Surgery and Biomedicine 
University Hospital Basel, CH


Enclosures


Present Survey Materials

Survey Guidelines for Reporting
Example Survey
Cellular Therapy and Regenerative Medicine Survey 2016 (Excel) - for Online Submission


Past Survey Reports
The Survey on Cellular and Engineered Tissue Therapies in Europe 2008

The Survey on Cellular and Engineered Tissue Therapies in Europe 2009
The Survey on Cellular and Engineered Tissue Therapies in Europe 2010
The Survey on Cellular and Engineered Tissue Therapies in Europe 2011
The Survey on Cellular and Engineered Tissue Therapies in Europe 2012
The Survey on Cellular and Engineered Tissue Therapies in Europe 2013
The Survey on Cellular and Engineered Tissue Therapies in Europe and neighboring Eurasian countries in 2014 and 2015


 


© 2017 International Society for Cellular Therapy. All rights reserved.
ISCT, International Society for Cellular Therapy, and the ISCT logo are registered service marks of The International Society for Cellular Therapy.
The BEACON and lighthouse logo is a service mark of The International Society for Cellular Therapy.